Selection strategy of second-line biologic therapies in adult patients with ulcerative colitis following prior biologic treatment failure: Systematic review and meta-analysis
Background: Optimizing second-line biologic therapies for adult ulcerative colitis (UC) post first-line failure is essential. Objective: Compare second-line biologic therapy efficacy in adult UC patients with prior treatment failure. Methods: A comprehensive search of electronic databases up to May...
Saved in:
Main Authors: | Hu Zhang (Author), Chenlu Mu (Author), Yu Gu (Author), Fanyi Meng (Author), Xiali Qin (Author), Hailong Cao (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Biologics for the treatment of moderate- to-severe ulcerative colitis in pediatric patients
by: Albenberg LG, et al.
Published: (2012) -
Factors influencing the discontinuation of biologic therapies in patients with ulcerative colitis
by: Arisa Fukuyama, et al.
Published: (2024) -
The Ulcerative colitis - ustekinumab as a new biologic therapy, review 2024
by: Zuzanna Felińska, et al.
Published: (2024) -
Biologics in the management of ulcerative colitis – comparative safety and efficacy of TNF-α antagonists
by: Fausel R, et al.
Published: (2015) -
BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN'S DISEASE: BUDGET IMPACT ANALYSIS
by: E. A. Pyadushkina
Published: (2017)